Skincare founder Dr. Barbara Sturm says you only need these two products for healthy aging. 🔗 https://t.co/MMtmkXIYVL https://t.co/jVxmzy5dfl ...

Mar 18, 2026 8:32 AM Eastern Daylight Time Niagen Bioscience to Present at the 38th Annual ROTH Conference Share Niagen Bioscience to Present at the 38th Annual ROTH Conference LOS ANGELES--(BUSINESS WIRE)-- Niagen Bioscience, Inc.(NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate at the 38th Annual ROTH Conference, taking place at The Ritz-Carlton Laguna Niguel in Dana Point, ...

Skincare founder Dr. Barbara Sturm says you only need these two products for healthy aging. 🔗 https://t.co/MMtmkXIYVL https://t.co/c829sTvTYh ...

Skincare founder Dr. Barbara Sturm says you only need these two products for healthy aging. 🔗 https://t.co/fCVS1BJn6B https://t.co/90SO1MQvLm ...

my amazing mother. He >> I didn't know my first name was amazing, >> but I am delighted to see so many beautiful faces that I know and trust. And I'm not quite sure how much longer I'm going to live, but I know whoever's out here is going to do one heck of a job.>> Yeah. >> So, and I want everyone to live well into their 90s. Genetics are important, but there are four things you can do that will absolutely help.Number one is pingpong. Pingpong is the very best activity seniors can do for their brain. The ge ...

Now for the next two minutes, I would like you to lay back on your seat and listen to my voice. Please close your eyes and focus on your breathing. You inhale from your nose. You exhale from your mouth.You're more focused, relaxed once again. Inhale. Exhale.Feel more energetic. Once more. Inhale.Exhale. And now that you are focused, I want you to think what you did yesterday. See it like a movie in your mind.You got out of bed. You woke up. You had your breakfast.You went to work. You had your lunch. You ha ...

Core Insights - Niagen Bioscience has announced the sale of its ChromaDex Reference Standards business to LGC in an all-cash transaction, aimed at streamlining operations and focusing on core activities related to NAD+ science and healthy aging [1] Company Strategy - The divestiture is part of Niagen Bioscience's strategy to exit non-core activities and allocate resources towards NAD+ science, intellectual property, and commercial growth within the longevity industry [1] - CEO Rob Fried emphasized that this transaction allows the company to focus on advancing NAD+ science and delivering patented Niagen® solutions [1] Acquisition Details - The sale to LGC is expected to enhance LGC's capabilities in supporting pharmaceutical customers, testing laboratories, and food producers by expanding their reference materials and analytical standards portfolio [1] - LGC Standards, a division of LGC Group, is recognized as a global leader in life sciences and analytical solutions [1] Market Position - Niagen Bioscience is positioned as a leader in NAD+ science and healthy aging research, with a focus on innovative NAD+-boosting solutions [1] - The company’s flagship product, Niagen®, is noted as the most efficient and well-researched NAD+ booster available [1] Future Outlook - Niagen Bioscience is dedicated to advancing healthspan through precision science and innovative solutions, with a robust patent portfolio protecting its NAD+ precursors [1]

Core Viewpoint - Niagen Bioscience, Inc. is positioned as a leader in NAD+ research and is actively promoting the science of healthy aging through its sponsorship of a significant scientific meeting [1] Company Summary - Niagen Bioscience, Inc. (NASDAQ: NAGE) is recognized as the global authority on NAD+ [1] - The company is focusing on the science of healthy aging, indicating its commitment to advancing research in this area [1] Event Summary - Niagen Bioscience is the headlining sponsor of the inaugural NAD for Health: Opportunities & Challenges scientific meeting [1] - The event will be hosted by the University of Copenhagen from March 23 to March 25, 2026 [1] - The meeting will take place at the Royal Danish Academy of Sciences and Letters in central Copenhagen, highlighting its prestigious location [1] - Registration is required for attendance, and space is limited, indicating the event's exclusivity [1]

Core Viewpoint - Celularity Inc. has successfully closed a financing transaction, enhancing its financial position and supporting its strategic initiatives in regenerative and cellular medicine [1][4]. Financing Details - Celularity received $10.00 million in gross proceeds from the financing, with the potential for an additional $2.0 million based on specific conditions [2]. - The financing structure includes a senior secured term loan of $7.0 million and secured convertible notes with commitments of up to $5.0 million, convertible at a price of $1.66 per share [3]. - The secured convertible notes are backed by a first-priority lien on proceeds from a qualified financing, and Celularity issued warrants for 3,707,657 shares of Class A Common Stock with an exercise price of $2.00 per share [3]. Strategic Focus - The company aims to leverage its placental-derived platform to address significant unmet medical needs related to healthy aging and performance optimization [4]. - Celularity plans to articulate its corporate strategy in the upcoming year, aligning its scientific capabilities with long-term opportunities in longevity and age-related diseases [5]. Company Overview - Celularity Inc. specializes in developing, manufacturing, and commercializing advanced biomaterial products and cell therapies derived from postpartum placenta, targeting fundamental aging mechanisms [7].

Core Viewpoint - Niagen Bioscience, Inc. has raised its full-year 2025 net sales outlook to a growth rate of 25% to 30% year-over-year, up from a previous estimate of 22% to 27% [1] Company Summary - Niagen Bioscience, Inc. is recognized as a global authority on NAD+ (nicotinamide adenine dinucleotide) and focuses on the science of healthy aging [1] - The company emphasizes the importance of elevating NAD+ levels for health, particularly as individuals age, highlighting the significance of this area of science for public health [1]